Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 63 (PPIAP63)

Target: PPIAP63
Molecular classification: Pseudogene

Overview

Peptidylprolyl isomerase A pseudogene 63 (PPIAP63) is a human gene classified as a pseudogene, meaning it is a non-functional sequence derived from the parental cyclophilin A (PPIA) gene. Pseudogenes such as PPIAP63 do not encode proteins and typically lack biological activity. PPIAP63 does not serve as a drug target, receptor, or enzyme, nor is it implicated in human disease or as a biomarker[1][3][6].

Other names: PPIAP63

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 63 (PPIAP63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 63 (PPIAP63).

Explore the full profile